Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | SI | P14410 | 2/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1406401 | 0.91 | MGAM (0.42) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL6022632 | 0.81 | MGAM (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL7195368 | 0.79 | LMNA (0.39) | GAAALDH1A1TSHRSMN1; SMN2USP2 | |
| SCHEMBL30683844 | 0.77 | ALDH1A1 (0.40) | GAAALDH1A1TSHRSMN1; SMN2USP2 | |
| SCHEMBL11905900 | 0.73 | TSHR (0.42) | ALDH1A1TSHRSMN1; SMN2USP2LMNA | |
| SCHEMBL258590 | 0.73 | LMNA (0.33) | ALDH1A1TSHRSMN1; SMN2USP2LMNA | |
| SCHEMBL130199 | 0.73 | TSHR (0.42) | ALDH1A1TSHRSMN1; SMN2USP2LMNA | |
| SCHEMBL622706 | 0.73 | TSHR (0.42) | ALDH1A1TSHRSMN1; SMN2USP2LMNA | |
| SCHEMBL128830 | 0.73 | TSHR (0.42) | ALDH1A1TSHRSMN1; SMN2USP2LMNA | |
| SCHEMBL3088953 | 0.73 | CYP2C19 (0.33) | ALDH1A1TSHRSMN1; SMN2USP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12187923-B2 | Michael-addition-hardening synthetic resin for chemical fixing technology | FISCHERWERKE GMBH & CO. KG (DE) | 2025-01-07 | — | — | US | claimed |
| US-12180394-B2 | Michael-addition-hardening hybrid system for chemical fixing technology | FISCHERWERKE GMBH & CO. KG (DE) | 2024-12-31 | — | — | US | claimed |
| WO-2023139231-A1 | RESIN COMPOSITION | ARXADA AG (CH) | 2023-07-27 | — | — | WO | claimed |
| US-20230002653-A1 | MICHAEL-ADDITION-HARDENING HYBRID SYSTEM FOR CHEMICAL FIXING TECHNOLOGY | FISCHERWERKE GMBH & CO. KG (DE) | 2023-01-05 | — | — | US | claimed |
| US-20220411680-A1 | MICHAEL-ADDITION-HARDENING SYNTHETIC RESIN FOR CHEMICAL FIXING TECHNOLOGY | FISCHERWERKE GMBH & CO. KG (DE) | 2022-12-29 | — | — | US | claimed |
| CN-114729224-A | Michael addition hardening hybrid system for chemical fixation technology | 费希尔厂有限责任两合公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114729253-A | Michael addition hardening synthetic resin for chemical fixing technology | 费希尔厂有限责任两合公司 | 2022-07-08 | — | — | CN | claimed |
| CN-111010876-B | Encapsulation method | 陶氏环球技术有限责任公司 | 2022-01-11 | — | — | CN | claimed |
| CN-110959036-B | Detergent additive | 陶氏环球技术有限责任公司 | 2022-01-04 | — | — | CN | claimed |
| CN-111010876-A | Encapsulation method | 陶氏环球技术有限责任公司 | 2020-04-14 | — | — | CN | claimed |
| CN-110959036-A | Detergent additive | 陶氏环球技术有限责任公司 | 2020-04-03 | — | — | CN | claimed |
| US-9340644-B2 | Self-sensitive polymerizable liquid resin and use thereof | ETERNAL MATERIALS CO., LTD. (TW) | 2016-05-17 | — | — | US | claimed |
| EP-2087058-A2 | RELEASE SHEETS AND METHODS OF MAKING THE SAME | S.D. Warren Company (US) | 2009-08-12 | — | — | EP | claimed |
| WO-2008055026-A2 | RELEASE SHEETS AND METHODS OF MAKING THE SAME | S.D. WARREN COMPANY (US) | 2008-05-08 | — | — | WO | claimed |
| US-20080102271-A1 | Release sheets and methods of making the same | S.D. WARREN COMPANY | 2008-05-01 | — | — | US | claimed |
| US-5017649-A | Low temperature crosslinking | EASTMAN KODAK COMPANY (US) | 1991-05-21 | — | — | US | claimed |
| US-12359080-B2 | Aqueous dispersion of capsules | AGFA-GEVAERT NV (BE) | 2025-07-15 | — | — | US | disclosed |
| US-12252622-B2 | Aqueous dispersion of resin particles | AGFA-GEVAERT NV (BE) | 2025-03-18 | — | — | US | disclosed |
| WO-1996012579-A1 | FOUNDRY MIXES AND THEIR USES | ASHLAND INC. (US) | 1996-05-02 | — | — | WO | disclosed |
| US-5459178-A | Aggregate and binder comprising an acetoacetate ester, di-or triacrylate and a liquid tertiary amine catalyst; foundry shapes made by no-bake process | ASHLAND INC. (US) | 1995-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12359080-B2 | Aqueous dispersion of capsules | RER1, CHRM1, CRHR1 | MGAM 4029/4885GAA 4337/4885SI 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.